ASTRO's Advances in Radiation Oncology’s Top 20 Downloads for 2022

Our top downloads for the ASTRO's Advances in Radiation Oncology in 2022 were focused on a variety of topics, reflecting shifting interests in our profession with reirradiation, hypofractionation, and symptom management to improve both the short-term and long-term quality of life of our patients. Table 1 contains a list and links to our 20 most downloaded articles in 2022. Approximately half of our top 20 downloads relate to hypofractionation and reirradiation/symptom management. Although we continue to publish a handful of COVID-19-related articles, this topic no longer has the clinical urgency that was seen in 2020 and 2021.Table 1Top 20 downloads from ASTRO's Advances in Radiation Oncology during 2022DOI addressArticle titleFirst authorhttps://doi.org/10.1016/j.adro.2020.100640Reirradiation for Locoregional Recurrent Breast CancerFattahi, S.https://doi.org/10.1016/j.adro.2022.100912Interventions for Radiation-Induced Fibrosis in Patients With Breast Cancer: Systematic Review and Meta-analysesNogueira, R.https://doi.org/10.1016/j.adro.2021.100732A Review and Analysis of Managing Commonly Seen Implanted Devices for Patients Undergoing Radiation TherapyChan, M.https://doi.org/10.1016/j.adro.2020.09.011Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response StudyRasmusson, E.https://doi.org/10.1016/j.adro.2018.09.006The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients With pT2N0R0 Prostate Cancer? A Multi-Institutional StudyKraus, R.https://doi.org/10.1016/j.adro.2022.100909A Patient-Level Data Meta-analysis of the Abscopal EffectHatten, S.https://doi.org/10.1016/j.adro.2021.100877Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast CancerCorrigan, K. J.https://doi.org/10.1016/j.adro.2021.100653An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung CancerRulach, R.https://doi.org/10.1016/j.adro.2021.100850Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue SarcomaBedi, M.https://doi.org/10.1016/j.adro.2020.100639Spatially Fractionated Stereotactic Body Radiation Therapy (Lattice) for Large TumorsDuriseti, S.https://doi.org/10.1016/j.adro.2022.100941Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 TrialShee, K.https://doi.org/10.1016/j.adro.2022.100919Characterizing Twitter Influencers in Radiation OncologyValle, L.https://doi.org/10.1016/j.adro.2021.100708The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic RadiosurgeryThrower, S.https://doi.org/10.1016/j.adro.2020.09.016Evaluation of Mobile Health Applications to Track Patient-Reported Outcomes for Oncology Patients: A Systematic ReviewLu, D.https://doi.org/10.1016/j.adro.2021.100871Rapid and Durable Symptom Palliation With Quad Shot Radiation Therapy to Nonosseous Metastatic/Recurrent Cancer in Elderly or Frail Patients in a Rural Community ClinicKil, W.https://doi.org/10.1016/j.adro.2021.100878Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution ExperienceKent, C. W.https://doi.org/10.1016/j.adro.2022.100906Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine MetastasisShin, J.https://doi.org/10.1016/j.adro.2021.100723Adverse Effects of Total Body Irradiation: A Two-Decade, Single Institution AnalysisPearlman, R.https://doi.org/10.1016/j.adro.2021.100713Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation TherapyMcLaughlin, M.https://doi.org/10.1016/j.adro.2022.100913Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma LesionsBoyce-Fappiano, D. Open table in a new tab Our most downloaded article, by Fattahi et al, continues to be the Mayo Clinic study on breast reirradiation. This article reported outcomes that suggest that “[r]eirradiation for locoregional recurrent breast cancer is feasible with acceptable rates of toxicity. Disease control and survival are promising among curative intent reirradiation patients without gross disease.”1Fattahi S Ahmed SK Park SS et al.Reirradiation for locoregional recurrent breast cancer.Adv Radiat Oncol. 2020; 6100640PubMed Google Scholar Our second most downloaded article, from Chan et al, also focused on breast cancer and was a systematic review and meta-analysis of the literature on radiation-induced fibrosis after breast radiation. The authors suggested that “[a]lthough isolated studies show significant results favorable to the experimental groups, caution should be exercised in these findings because of the small number, small sample size, and high risk of bias presented by some of the included studies, which makes the recommendation for clinical practice still weak.”2Nogueira RMP Vital FMR Bernabé DG Carvalho MB. Interventions for radiation-induced fibrosis in patients with breast cancer: Systematic review and meta-analyses.Adv Radiat Oncol. 2022; 7100912Google Scholar Coming in at number three was a review of issues associated with irradiating patients with implantable medical devices, an area where allowances must be made for a wide variety of devices that now include not only cardiac pacemakers but also “implanted cardiac defibrillators, programmable hepatic pumps, pain pumps, neurostimulators, cerebral shunts, and loop recorders.” The article includes a sample workflow incorporating each of these devices, with risk categories based on AAPM TG-203.3Chan MF Young C Gelblum D et al.A review and analysis of managing commonly seen implanted devices for patients undergoing radiation therapy.Adv Radiat Oncol. 2021; 6100732Google Scholar Our fourth and fifth most downloaded articles are related to prostate cancer, the fourth focusing on the long-term risk of hip complications4Rasmusson E Nilsson P Kjellén E Gunnlaugsson A. Long-term risk of hip complications after radiation therapy for prostate cancer: A dose-response study.Adv Radiat Oncol. 2020; 6100571Google Scholar and the fifth on the prognostic value of perineural invasion in patients with pT2N0R0 prostate cancer.5Kraus RD Barsky A Ji L et al.The perineural invasion paradox: Is perineural invasion an independent prognostic indicator of biochemical recurrence risk in patients with pT2N0R0 prostate cancer? A multi-institutional study.Adv Radiat Oncol. 2018; 4: 96-102Abstract Full Text Full Text PDF Scopus (18) Google Scholar Our journal continues to grow in readership and citations. Table 2 contains our top 5 most citated articles in 2022. We anticipate receiving an Impact Factor later this year. Currently, our CiteScore, an alternative measure of impact using 4 years of data rather than data from the previous 2 years that Impact Factor measures, is 4.3 (Fig. 1). With a total 6266 citations of our journal articles published between 2016 and 2022, Advances is the global leader among open-access radiation journals for number of citations (Fig. 2). As an open-access journal, Advances is always freely available to any health care professional or researcher in the world. It is also freely available to our patients, their families, and patient advocacy groups around the world (Fig. 3).Table 2Top cited articles in ASTRO's Advances in Radiation Oncology in the past 3 yearsDOI addressArticle titleFirst authorCitedhttps://doi.org/10.1016/j.adro.2020.03.010Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Zaorsky, N. G.129https://doi.org/10.1016/j.adro.2020.03.013Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints—Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United StatesBraunstein, L. Z.77https://doi.org/10.1016/j.adro.2020.03.003Running a Radiation Oncology Department at the Time of Coronavirus: An Italian ExperienceKrengli, M.55https://doi.org/10.1016/j.adro.2020.06.010Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided AdaptationHassanzadeh, C.49https://doi.org/10.1016/j.adro.2020.03.006The Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United StatesRivera, A.48 Open table in a new tab Figure 2Growth in citations per year for ASTRO's Advances in Radiation Oncology from 2015 to 2022.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 3Global distribution of ASTRO's Advances in Radiation Oncology during 2022.View Large Image Figure ViewerDownload Hi-res image Download (PPT)

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.